Mrinal Patnaik (@mrinalpatnaik) 's Twitter Profile
Mrinal Patnaik

@mrinalpatnaik

Director Precision Genomics Clinic, Chronic Myelomonocytic Leukemia Epigenetics lab, Hematology, Mayo Clinic, Minnesota. ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡บ๐Ÿ‡ธGSD and ๐ŸŽพ๐Ÿfan for life!

ID: 1160009240918089731

calendar_today10-08-2019 02:05:29

1,1K Tweet

3,3K Followers

602 Following

NEJM (@nejm) 's Twitter Profile Photo

Second tumors after CAR T-cell therapy are rare, and in one case of a secondary T-cell lymphoma, detailed analysis showed that the genetic construct that was used to make the CAR T cells was unrelated to the second tumor. Read the full study results: nej.md/3Rln392

Second tumors after CAR T-cell therapy are rare, and in one case of a secondary T-cell lymphoma, detailed analysis showed that the genetic construct that was used to make the CAR T cells was unrelated to the second tumor. Read the full study results: nej.md/3Rln392
Mrinal Patnaik (@mrinalpatnaik) 's Twitter Profile Photo

ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions Clifford Csizmar Eric Padron MD Guillermo Montalban-Bravo Rami komrokji #CMML #TET2 #ASXL1TET2 Haematologica pubmed.ncbi.nlm.nih.gov/38899337/

Nature Portfolio (@natureportfolio) 's Twitter Profile Photo

Two papers in nature present a new genome editing technique that enables the insertion, inversion and deletion of long DNA sequences at user-specified genome positions. The approach may provide an easier method of genome editing. go.nature.com/3RGkI8M go.nature.com/3RHBvIs

Two papers in <a href="/Nature/">nature</a> present a new genome editing technique that enables the insertion, inversion and deletion of long DNA sequences at user-specified genome positions. The approach may provide an easier method of genome editing.
go.nature.com/3RGkI8M 
go.nature.com/3RHBvIs
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

Next up at #iwMPN24 Mrinal Patnaik (Mayo Clinic Comprehensive Cancer Center) talks on RASopathies, key features of RAS family-mutated chronic myelomonocytic leukemia and treatment options VJHemOnc #iwMDS24 #iwMPN24 #MPN #MPNsm #CMML

Next up at #iwMPN24 <a href="/MrinalPatnaik/">Mrinal Patnaik</a> (<a href="/MayoCancerCare/">Mayo Clinic Comprehensive Cancer Center</a>) talks on RASopathies, key features of RAS family-mutated chronic myelomonocytic leukemia and treatment options

<a href="/VJHemOnc/">VJHemOnc</a> #iwMDS24 #iwMPN24 #MPN #MPNsm #CMML
Mayo Clinic Comprehensive Cancer Center (@mayocancercare) 's Twitter Profile Photo

Hair follicle DNA extraction for germline testing in hematologic malignancies improves process efficiency, patient care and reduces costs, allowing for quicker treatment decision-making. Mayo Clinic hematologist-oncologist Dr. @mrinalpatnaik explains how: mayocl.in/45Mge6k

Hair follicle DNA extraction for germline testing in hematologic malignancies improves process efficiency, patient care and reduces costs, allowing for quicker treatment decision-making. <a href="/MayoClinic/">Mayo Clinic</a> hematologist-oncologist Dr. @mrinalpatnaik explains how: mayocl.in/45Mge6k
Mayo Clinic Comprehensive Cancer Center (@mayocancercare) 's Twitter Profile Photo

Hair follicle DNA extraction for germline testing in hematologic malignancies improves process efficiency, patient care and reduces costs, allowing for quicker treatment decision-making. Mayo Clinic hematologist-oncologist Dr. @mrinalpatnaik explains how: mayocl.in/3RZJMrI

Hair follicle DNA extraction for germline testing in hematologic malignancies improves process efficiency, patient care and reduces costs, allowing for quicker treatment decision-making. <a href="/MayoClinic/">Mayo Clinic</a> hematologist-oncologist Dr. @mrinalpatnaik explains how: mayocl.in/3RZJMrI
Biology Deconstructed (@biologymusings) 's Twitter Profile Photo

Genentech published a sequencing comparison of all commercial single-cell technologies two weeks ago. Fluent offers a low cost per cell but has a long way to match 10x in sensitivity. ILMN could go for 10x/Parse, probably didnโ€™t want to upset their friends at the FTC..again

Genentech published a sequencing comparison of all commercial single-cell technologies two weeks ago. Fluent offers a low cost per cell but has a long way to match 10x in sensitivity.
ILMN could go for 10x/Parse, probably didnโ€™t want to upset their friends at the FTC..again
Mrinal Patnaik (@mrinalpatnaik) 's Twitter Profile Photo

Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia โ€ฆ pubmed.ncbi.nlm.nih.gov/38976813/ yael kusne MD PhD Terra Lasho, PhD #Lutetium #CH #Radiotheranostics Mayo Clinic Comprehensive Cancer Center

Mrinal Patnaik (@mrinalpatnaik) 's Twitter Profile Photo

Absence of PNH-clones in DDX41mutant-GPS aids in their distinction from acquired bone marrow failure syndromes ... sciencedirect.com/science/articlโ€ฆ yael kusne MD PhD Tim Chlon Talha Badar Mayo Clinic Comprehensive Cancer Center #DDX41 #Bonemarrowfailure

Mrinal Patnaik (@mrinalpatnaik) 's Twitter Profile Photo

Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program | Science science.org/doi/10.1126/scโ€ฆ

VJHemOnc (@vjhemonc) 's Twitter Profile Photo

#MPNWorkshopNC | Mrinal Patnaik of Mayo Clinic is first up in the session on rare & overlap syndromes with his talk, 'Novel Therapeutic Targets in CMML'. This is sure to be an interesting session!๐Ÿ‘ Atrium Health South Piedmont AHEC #MPNsm #HemOnc

#MPNWorkshopNC | <a href="/MrinalPatnaik/">Mrinal Patnaik</a> of <a href="/MayoClinic/">Mayo Clinic</a> is first up in the session on rare &amp; overlap syndromes with his talk, 'Novel Therapeutic Targets in CMML'.

This is sure to be an interesting session!๐Ÿ‘

<a href="/AtriumHealth/">Atrium Health</a> <a href="/spahec/">South Piedmont AHEC</a> #MPNsm #HemOnc
Elizabeth McKenna (@elizsmckenna) 's Twitter Profile Photo

Now online in Cancer Discovery: RNA shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-mutated #ClonalHematopoiesis - by Nana Adjoa Ben-Crentsil, Alexandre Gaspar Maia Mrinal Patnaik Eric Padron MD and colleagues doi.org/10.1158/2159-8โ€ฆ Mayo Clinic Moffitt Cancer Center

Now online in <a href="/CD_AACR/">Cancer Discovery</a>: RNA shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-mutated #ClonalHematopoiesis - by Nana Adjoa Ben-Crentsil, <a href="/gasparma1a/">Alexandre Gaspar Maia</a> <a href="/MrinalPatnaik/">Mrinal Patnaik</a> <a href="/md_padron/">Eric Padron MD</a> and colleagues doi.org/10.1158/2159-8โ€ฆ  <a href="/MayoClinic/">Mayo Clinic</a> <a href="/MoffittNews/">Moffitt Cancer Center</a>